Sources

Every claim on this site links back to a peer-reviewed study or authoritative industry source. If you ever spot something we got wrong, email tannerhaslinger@suppvis.health.

Where Our Research Comes From

Every supplement, drug, condition, and habit in SuppVis is grounded in research from authoritative public databases. We index, classify, and link evidence so every claim traces back to its source.

PubMed

National Library of Medicine

Peer-reviewed biomedical research articles across every domain we track.

Visit

ClinicalTrials.gov

National Library of Medicine

Registry of publicly and privately supported clinical trials. Source for emerging peptide and drug evidence.

Visit

RxNorm

National Library of Medicine

Standard nomenclature for clinical drugs. Used to normalize every medication in our database.

Visit

RxClass

National Library of Medicine

Drug classification system linking medications to pharmacological classes and mechanisms.

Visit

DailyMed

NLM and FDA

Official source for FDA-approved drug labeling. Backbone of our drug-supplement interaction data.

Visit

MedlinePlus

National Library of Medicine

Patient-facing health information reviewed by physicians. Source for condition descriptions.

Visit

NIH Office of Dietary Supplements

National Institutes of Health

Federal authority on dietary supplement research, dosing, and safety.

Visit

NIH Dietary Supplement Label Database

National Institutes of Health

Comprehensive database of supplement product labels, ingredients, and barcodes.

Visit

Semantic Scholar

Allen Institute for AI

AI-powered academic search. Surfaces relevant research that pure keyword indexing misses.

Visit

Studies are classified by type (randomized controlled trials, meta-analyses, systematic reviews, observational, animal, mechanistic) and weighted toward higher-evidence study types in our recommendations. The corpus updates continuously.

These sources are publicly accessible authoritative databases used by SuppVis to inform its platform. SuppVis is not affiliated with, sponsored by, or endorsed by the National Library of Medicine, the National Institutes of Health, the U.S. Department of Health and Human Services, the FDA, the Allen Institute for AI, or any other listed organization. Inclusion of a source does not imply endorsement by that source.

Homepage

  1. [1] $69.3B spent on supplements in 2024

    Nutrition Business Journal, "State of Supplements" report, 2024. Reported via Nutraceuticals World, April 2025.

    View source →

  2. [2] 1 in 3 U.S. adults takes a prescription medication alongside a supplement

    Farina EK, Austin KG, Lieberman HR. "Concomitant dietary supplement and prescription medication use is prevalent among US adults with doctor-informed medical conditions." J Acad Nutr Diet. 2014;114(11):1784-90.

    View source →

  3. [3] Only 26.9% of supplements were recommended by a doctor

    NHANES 2011–2018 dataset analysis. "Quantity, Duration, Adherence, and Reasons for Dietary Supplement Use among Adults." Nutrients. 2024.

    View source →

  4. [4] 16% of U.S. adults take four or more supplements daily

    NHANES 2021–2023 cycle data. "Trends in dietary supplement use among U.S. adults between 2011 and 2023." European Journal of Nutrition. 2025.

    View source →